Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor

Yuanying Fang, Lamees Hegazy, Brian N. Finck and Bahaa Elgendy

J. Med. Chem., 2021, 64, 17545
DOI: 10.1021/acs.jmedchem.1c01017

Structure‐Based Optimization of Novel Farnesoid X Receptor Agonist for the Treatment of Acetaminophen‐Induced Liver Injury

Dongchan Feng, Yan Tang, Huawei Qiu, Li Zhang and Dan Wu

ChemistrySelect, 2022, 7
DOI: 10.1002/slct.202200538

Discovery of quorum sensing inhibitors of Pseudomonas fluorescens P07 by using a receptor-based pharmacophore model and virtual screening

Ting Ding, Tingting Li and Jianrong Li

LWT, 2019, 109, 171
DOI: 10.1016/j.lwt.2019.04.030

Pose Filter-Based Ensemble Learning Enables Discovery of Orally Active, Nonsteroidal Farnesoid X Receptor Agonists

Jie Xia, Zhenyi Wang, Yi Huan, Wenjie Xue, Xing Wang, Yuxi Wang, Zhenming Liu, Jui-Hua Hsieh, Liangren Zhang, Song Wu, Zhufang Shen, Hongmin Zhang and Xiang Simon Wang

J. Chem. Inf. Model., 2020, 60, 1202
DOI: 10.1021/acs.jcim.9b01030

Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts

Ko Fujimori, Yusuke Iguchi, Yukiko Yamashita, Keigo Gohda and Naoki Teno

Molecules, 2019, 24, 4155
DOI: 10.3390/molecules24224155

Design, synthesis, and biological evaluation of novel FXR agonists based on auraptene

Qianqian Qiu, Yanjuan Wang, Guolong Gu, Fan Yu, Shichao Zhang, Yining Zhao and Bai Ling

Bioorganic Chemistry, 2021, 115, 105198
DOI: 10.1016/j.bioorg.2021.105198

Screening inhibitor to prevent the psychrotrophic growth of Pseudomonas fluorescens by using molecular simulation

Congnan Cen, Jian Chen, Xiaochuan Wu, Linglin Fu and Yanbo Wang

Food Control, 2022, 134, 108557
DOI: 10.1016/j.foodcont.2021.108557